Global 1,3-Dihydroxyadamantane Market Growth 2025-2031
Description
The global 1,3-Dihydroxyadamantane market size is predicted to grow from US$ 49.9 million in 2025 to US$ 65.2 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
1,3-Dihydroxyadamantane (C10H16O2) is an organic compound that belongs to the class of adamantane derivatives. It has two hydroxyl groups (-OH) attached to the 1st and 3rd positions of the adamantane structure, which is a fused bicyclic compound.
United States market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 1,3-Dihydroxyadamantane players cover Kerton Chemicals, Matrix Fine Chemicals GmbH, Tianjin Minxiang Biomedical, Sichuan Zhongbang New Material, Hunan Chemfish Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “1,3-Dihydroxyadamantane Industry Forecast” looks at past sales and reviews total world 1,3-Dihydroxyadamantane sales in 2024, providing a comprehensive analysis by region and market sector of projected 1,3-Dihydroxyadamantane sales for 2025 through 2031. With 1,3-Dihydroxyadamantane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1,3-Dihydroxyadamantane industry.
This Insight Report provides a comprehensive analysis of the global 1,3-Dihydroxyadamantane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1,3-Dihydroxyadamantane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 1,3-Dihydroxyadamantane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1,3-Dihydroxyadamantane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1,3-Dihydroxyadamantane.
This report presents a comprehensive overview, market shares, and growth opportunities of 1,3-Dihydroxyadamantane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity99%
Others
Segmentation by Application:
Pharmaceutical Synthesis
Photosensitive Material
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kerton Chemicals
Matrix Fine Chemicals GmbH
Tianjin Minxiang Biomedical
Sichuan Zhongbang New Material
Hunan Chemfish Pharmaceutical
Shaoxing Catsyn
Yibin chemist Pharmachem
Shanghai Daeyeon Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1,3-Dihydroxyadamantane market?
What factors are driving 1,3-Dihydroxyadamantane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1,3-Dihydroxyadamantane market opportunities vary by end market size?
How does 1,3-Dihydroxyadamantane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
1,3-Dihydroxyadamantane (C10H16O2) is an organic compound that belongs to the class of adamantane derivatives. It has two hydroxyl groups (-OH) attached to the 1st and 3rd positions of the adamantane structure, which is a fused bicyclic compound.
United States market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 1,3-Dihydroxyadamantane is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 1,3-Dihydroxyadamantane players cover Kerton Chemicals, Matrix Fine Chemicals GmbH, Tianjin Minxiang Biomedical, Sichuan Zhongbang New Material, Hunan Chemfish Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “1,3-Dihydroxyadamantane Industry Forecast” looks at past sales and reviews total world 1,3-Dihydroxyadamantane sales in 2024, providing a comprehensive analysis by region and market sector of projected 1,3-Dihydroxyadamantane sales for 2025 through 2031. With 1,3-Dihydroxyadamantane sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 1,3-Dihydroxyadamantane industry.
This Insight Report provides a comprehensive analysis of the global 1,3-Dihydroxyadamantane landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 1,3-Dihydroxyadamantane portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 1,3-Dihydroxyadamantane market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 1,3-Dihydroxyadamantane and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 1,3-Dihydroxyadamantane.
This report presents a comprehensive overview, market shares, and growth opportunities of 1,3-Dihydroxyadamantane market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Purity99%
Others
Segmentation by Application:
Pharmaceutical Synthesis
Photosensitive Material
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Kerton Chemicals
Matrix Fine Chemicals GmbH
Tianjin Minxiang Biomedical
Sichuan Zhongbang New Material
Hunan Chemfish Pharmaceutical
Shaoxing Catsyn
Yibin chemist Pharmachem
Shanghai Daeyeon Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global 1,3-Dihydroxyadamantane market?
What factors are driving 1,3-Dihydroxyadamantane market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 1,3-Dihydroxyadamantane market opportunities vary by end market size?
How does 1,3-Dihydroxyadamantane break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 1,3-Dihydroxyadamantane by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 1,3-Dihydroxyadamantane by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
